Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > I was looking at T.WELL... and it struck me that...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(64)
•••
Post by gojotv!on Jun 10, 2021 12:03am
175 Views
Post# 33360566

I was looking at T.WELL... and it struck me that...

I was looking at T.WELL... and it struck me that...If I were a Canadian healthcare conglomerate, centered in Western Canada, but looking at expanding...
  • telehealth and digital medical services
  • acquisitions, especially in breakthrough medical technologies
I'd have a great interest in companies like SZLS, as part of my array of disease prevention and treatment modalities. After all, the most profitable businesses are those that keep costs down.
I'm pretty sure I'm not the first person who's seen overlaps that could cause interest... And that interest is surely whittled to a sharp point by SZLS's unbelievable luck in positioning our PCR tests so well during the Covid crisis.
The best profits are surely yet to come on that one...
Which may explain the otherwise completely puzzling presence of so many braying, no-fact-sharing bashers on this board...
Yes... Such outlandish efforts to keep this share price down may make sense after all...
GL and do your DD!
Cheers!

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities